| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
02-17-2017, 03:27 PM
|
#1 | ||
|
|||
|
Member
|
Earlier this week, Sanofi Genzyme announced a clinical trial to test a drug designed for people with Parkinson’s disease (PD) who have a specific genetic mutation (GBA).
This study is a major step forward in PD research — it’s the first drug trial in which a person’s genetic status determines eligibility and is testing a potential therapy to slow or stop disease progression. Read more on The Michael J. Fox Foundation’s blog: First Trial Begins Testing Drug in People with GBA Mutation | Parkinson's Disease Best, Debi |
||
|
 Reply With Quote
|
| "Thanks for this!" says: | anagirl (02-18-2017), Betsy859 (02-18-2017), eds195 (02-19-2017), lab rat (02-20-2017), Nan Cyclist (03-15-2017), olsen (04-03-2017), RLSmi (02-19-2017), soccertese (02-18-2017), wxxu (02-21-2017) |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| 1st patientPhase I clinical trial of the regenerative cell therapy NTCELL - pig cells | Parkinson's Disease | |||
| Clinical trial of diabetic drug for Parkinson's disease | Parkinson's Disease | |||
| Pilot Clinical Trial: Insulin Therapy and Alzheimer's Disease | Alzheimer's Disease | |||
| My Experience in a Parkinson’s Clinical Trial...by JeanB | Parkinson's Disease | |||
| CLINICAL TRIAL...Safety Study of Gene Transfer Therapy in People with PD | Parkinson's Disease Clinical Trials | |||
First Therapy for Genetic Form of Parkinson’s Enters Clinical Trial
Threaded Mode